skip to content
Endocannabinoid regulation of monoamines in psychiatric and neurological disorders Preview this item
ClosePreview this item
Checking...

Endocannabinoid regulation of monoamines in psychiatric and neurological disorders

Author: Elisabeth J Van Bockstaele
Publisher: New York : Springer, ©2013.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Database:WorldCat
Summary:
The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
therapeutic use
drug therapy
Additional Physical Format: Print version:
Endocannabinoid regulation of monoamines in psychiatric.
[S.l.] : Springer-Verlag New York, 2013
(OCoLC)841520677
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Elisabeth J Van Bockstaele
ISBN: 9781461479406 1461479401 1461479398 9781461479390
OCLC Number: 852471079
Notes: Includes index.
Description: 1 online resource.
Contents: Endocannabinoids and monoamines: modulating the modulators --
Endocannabinoid-mediated synaptic plasticity --
Current cannabinoid receptor nomenclature and pharmacological principles --
Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction --
Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders --
Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers --
Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion --
Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function --
Endocannabinoids, Monoamines and Stress --
Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders --
Endocannabinoid Signaling and the Regulation of the Serotonin System --
Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors --
Involvement of serotonergic system in cannabinoid analgesia --
Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.
Responsibility: Elisabeth J. van Bockstaele, editor.
More information:

Abstract:

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders  Read more...

Reviews

Editorial reviews

Publisher Synopsis

From the reviews: "This book reviews the expansion of our understanding of cannabinoid modulation of monoaminergic circuits and their interactions in a variety of psychiatric and neurological Read more...

 
User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/852471079> # Endocannabinoid regulation of monoamines in psychiatric and neurological disorders
    a schema:MediaObject, schema:CreativeWork, schema:Book ;
    library:oclcnum "852471079" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/nyu> ;
    library:placeOfPublication <http://dbpedia.org/resource/New_York_City> ; # New York
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_psychiatry_psychopharmacology> ; # MEDICAL--Psychiatry--Psychopharmacology
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/cannabinoids_therapeutic_use> ; # Cannabinoids--Therapeutic use
    schema:about <http://id.worldcat.org/fast/845736> ; # Cannabinoids--Therapeutic use
    schema:about <http://id.worldcat.org/fast/1036124> ; # Nervous system--Diseases--Treatment
    schema:about <http://dewey.info/class/615.7827/e23/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/mental_illness_treatment> ; # Mental illness--Treatment
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/nervous_system_diseases> ; # Nervous System Diseases
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_pain_medicine> ; # MEDICAL--Pain Medicine
    schema:about <http://id.worldcat.org/fast/1016606> ; # Mental illness--Treatment
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/mental_disorders> ; # Mental Disorders
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/endocannabinoids> ; # Endocannabinoids
    schema:about <http://experiment.worldcat.org/entity/work/data/1411312578#Topic/nervous_system_diseases_treatment> ; # Nervous system--Diseases--Treatment
    schema:bookFormat schema:EBook ;
    schema:contributor <http://viaf.org/viaf/307434287> ; # Elisabeth J. Van Bockstaele
    schema:copyrightYear "2013" ;
    schema:datePublished "2013" ;
    schema:description "Endocannabinoids and monoamines: modulating the modulators -- Endocannabinoid-mediated synaptic plasticity -- Current cannabinoid receptor nomenclature and pharmacological principles -- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction -- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders -- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers -- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion -- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function -- Endocannabinoids, Monoamines and Stress -- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders -- Endocannabinoid Signaling and the Regulation of the Serotonin System -- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors -- Involvement of serotonergic system in cannabinoid analgesia -- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis."@en ;
    schema:description "The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing evidence from preclinical data suggesting that therapeutic use of cannabinoid-based drugs may outweigh any potential risks in certain serious medical conditions, the debate surrounding its widespread utility continues as regulatory concerns preclude a smooth transition of promising preclinical studies into clinical trial testing. This may persist in the near future as state and federal governments debate over regulation of medicinal applications of cannabis. Applications for medicinal cannabinoids that are already under investigation include the treatment of nausea, anorexia, neurodegeneration, inflammation, excitotoxicity and pain. The appetitive and anti-emetic properties of cannabinoids have led to the approval of their use in chemotherapy and AIDS patients. There is growing evidence for therapeutic cannabinoid effects on inflammatory and excitotoxic cellular processes that are linked to epilepsy, Parkinson's disease, amyotrophic lateral sclerosis, spasticity, and central nervous system injury. The chapters, herein, review and discuss current insights into the brain endocannabinoid system, cannabinoid receptor signaling on synaptic plasticity, potential therapeutic applications with a particular focus on endocannabinoid modulation of dopaminergic, noradrenergic and serotonergic circuitry. The potential for establishing cannabinoid-monoaminergic interactions as a novel target in the development of improved treatment strategies for psychiatric and neurological disorders is promising and will require future clinical studies to determine whether promising pre-clinical findings translate into new therapies."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/1411312578> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/841520677> ;
    schema:name "Endocannabinoid regulation of monoamines in psychiatric and neurological disorders"@en ;
    schema:productID "852471079" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/852471079#PublicationEvent/new_york_springer_2013> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/1411312578#Agent/springer> ; # Springer
    schema:url <http://dx.doi.org/10.1007/978-1-4614-7940-6> ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=606343> ;
    schema:url <http://swb.eblib.com/patron/FullRecord.aspx?p=1317800> ;
    schema:url <http://www.myilibrary.com?id=517034> ;
    schema:url <http://site.ebrary.com/id/10733550> ;
    schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=1317800> ;
    schema:workExample <http://worldcat.org/isbn/9781461479390> ;
    schema:workExample <http://worldcat.org/isbn/9781461479406> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/852471079> ;
    .


Related Entities

<http://dbpedia.org/resource/New_York_City> # New York
    a schema:Place ;
    schema:name "New York" ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/cannabinoids_therapeutic_use> # Cannabinoids--Therapeutic use
    a schema:Intangible ;
    schema:name "Cannabinoids--Therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_pain_medicine> # MEDICAL--Pain Medicine
    a schema:Intangible ;
    schema:name "MEDICAL--Pain Medicine"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/medical_psychiatry_psychopharmacology> # MEDICAL--Psychiatry--Psychopharmacology
    a schema:Intangible ;
    schema:name "MEDICAL--Psychiatry--Psychopharmacology"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/mental_illness_treatment> # Mental illness--Treatment
    a schema:Intangible ;
    schema:name "Mental illness--Treatment"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/nervous_system_diseases> # Nervous System Diseases
    a schema:Intangible ;
    schema:name "Nervous System Diseases"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411312578#Topic/nervous_system_diseases_treatment> # Nervous system--Diseases--Treatment
    a schema:Intangible ;
    schema:name "Nervous system--Diseases--Treatment"@en ;
    .

<http://id.worldcat.org/fast/1016606> # Mental illness--Treatment
    a schema:Intangible ;
    schema:name "Mental illness--Treatment"@en ;
    .

<http://id.worldcat.org/fast/1036124> # Nervous system--Diseases--Treatment
    a schema:Intangible ;
    schema:name "Nervous system--Diseases--Treatment"@en ;
    .

<http://id.worldcat.org/fast/845736> # Cannabinoids--Therapeutic use
    a schema:Intangible ;
    schema:name "Cannabinoids--Therapeutic use"@en ;
    .

<http://viaf.org/viaf/307434287> # Elisabeth J. Van Bockstaele
    a schema:Person ;
    schema:familyName "Van Bockstaele" ;
    schema:givenName "Elisabeth J." ;
    schema:name "Elisabeth J. Van Bockstaele" ;
    .

<http://worldcat.org/isbn/9781461479390>
    a schema:ProductModel ;
    schema:isbn "1461479398" ;
    schema:isbn "9781461479390" ;
    .

<http://worldcat.org/isbn/9781461479406>
    a schema:ProductModel ;
    schema:isbn "1461479401" ;
    schema:isbn "9781461479406" ;
    .

<http://www.worldcat.org/oclc/841520677>
    a schema:CreativeWork ;
    rdfs:label "Endocannabinoid regulation of monoamines in psychiatric." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/852471079> ; # Endocannabinoid regulation of monoamines in psychiatric and neurological disorders
    .

<http://www.worldcat.org/title/-/oclc/852471079>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/852471079> ; # Endocannabinoid regulation of monoamines in psychiatric and neurological disorders
    schema:dateModified "2015-11-07" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.